Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one
© 2015 Royal Pharmaceutical Society. Objectives Desferrioxamine (DFO), deferiprone (DFP) and deferasirox (DFX) are iron chelators currently in clinical use for the treatment of iron overload. Due to difficulties with administration and associated side effects with these three molecules, the search c...
Saved in:
Main Authors: | Pangjit K., Banjerdpongchai R., Phisalaphong C., Fucharoen S., Xie Y., Lu Z., Hider R., Srichairatanakool S. |
---|---|
Format: | Article |
Published: |
Pharmaceutical Press
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84928104155&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38461 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice
by: Kulprachakarn,K., et al.
Published: (2015) -
Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice
by: Chansiw N., et al.
Published: (2014) -
Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice
by: Chansiw,N., et al.
Published: (2015) -
Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice
by: Kanokwan Kulprachakarn, et al.
Published: (2018) -
Evaluation of a novel oral iron chelator 1-(N-acetyl-6-aminohexyl)-3-hydroxypyridin-4-one (CM1) for treatment of iron overload in mice
by: Somdet Srichairatanakool, et al.
Published: (2015)